Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Spark Therapeutics
Spark Therapeutics
Roche extends tender offer for Spark Therapeutics, again
Marketwatch
Mon, 12/9/19 - 11:42 pm
Roche
Spark Therapeutics
M&A
Disruptor of the Year: The Federal Trade Commission
Biopharma Dive
Mon, 12/9/19 - 11:16 pm
FTC
M&A
Roche
Spark Therapeutics
Put on hold music: Roche delays Spark buyout for the 9th — and quite possibly not the last — time
Endpoints
Fri, 11/22/19 - 10:37 am
Roche
M&A
Spark Therapeutics
Why Roche's Acquisition Of Spark May Be Complete By Year's End
Investors Business Daily
Sat, 10/26/19 - 02:14 pm
Roche
Spark Therapeutics
M&A
With biosimilar threat under control (for now), Roche savors demand for its new drugs
Endpoints
Wed, 10/16/19 - 12:24 pm
Roche
M&A
Spark Therapeutics
China
Roche sets new deadline for Spark acquisition as divestiture speculation brews
Endpoints
Mon, 09/30/19 - 12:00 pm
Roche
Spark Therapeutics
M&A
Roche-Spark deal review in U.K. unnerves M&A watchers—and they were spooked already
Fierce Pharma
Wed, 09/25/19 - 11:57 am
M&A
UK
Spark Therapeutics
Roche
antitrust
CMA
UK cost watchdog recommends Novartis' blindness therapy Luxturna
Yahoo/Reuters
Wed, 09/4/19 - 10:18 am
Novartis
gene therapy
Luxturna
UK
NICE
Spark Therapeutics
Roche stays mum about FTC, CMA reviews as $4.3B Spark deal faces yet another delay. What's up?
Endpoints
Tue, 09/3/19 - 10:56 am
Roche
Spark Therapeutics
FTC
CMA
M&A
The Week Ahead In Biotech: Pending Clinical Readouts, Earnings Dominate
Yahoo/Benzinga
Sun, 07/28/19 - 11:48 pm
biotech
earnings
Immunic
Alkermes
Conatus
Aevi Genomic
Tricida
Curis
Ultragenyx
Leap Therapeutics
Cidara Therapeutics
Akcea
Spark Therapeutics
Eli Lilly
AnaptysBio
clinical trials
Roche, Spark push back takeover deadline in $4.3 billion deal
Yahoo/Reuters
Mon, 07/8/19 - 09:44 am
Roche
Pharma CEOs
Severin Schwan
M&A
Spark Therapeutics
Sangamo backs up early success for hemophilia gene therapy
Biopharma Dive
Sat, 07/6/19 - 01:36 pm
Sangamo
gene therapy
hemophilia A
SB-525
Pfizer
Spark Therapeutics
Biomarin
The top 10 most-expensive meds in the U.S.—and they're not the usual suspects
Fierce Pharma
Thu, 06/13/19 - 12:14 pm
drug pricing
GoodRx
Novartis
Spark Therapeutics
Zolgensma
Luxturna
FTC demands could mean months-long delay for Roche-Spark deal
Biopharma Dive
Wed, 06/12/19 - 06:44 pm
Roche
Spark Therapeutics
FTC
M&A
Investors fret as new regulatory probes spur fresh delays to Roche's $4.3B Spark buyout
Endpoints
Mon, 06/10/19 - 07:38 pm
Spark Therapeutics
Roche
FTC
UK
M&A
What's taking the FTC so long? Roche won't say, but insists it will bag Spark on time — despite third delay
Endpoints
Tue, 05/14/19 - 11:05 am
Roche
Spark Therapeutics
M&A
Roche delays $4.3B Spark buyout — again — as FTC review drags on
Endpoints
Fri, 04/26/19 - 10:12 am
Roche
Spark Therapeutics
M&A
FTC
Roche must ask Spark shareholders once again to sell
Biopharma Dive
Wed, 04/3/19 - 12:23 pm
Roche
Spark Therapeutics
gene therapy
M&A
Gene therapy progress spurs competition in biotech buyouts
Biopharma Dive
Tue, 03/19/19 - 11:41 pm
biotech
gene therapy
M&A
Biogen
Nightstar Therapeutics
Roche
Spark Therapeutics
Spark bidding war drove Roche bid up by $2.1 billion
BioCentury
Thu, 03/7/19 - 09:46 pm
Spark Therapeutics
Roche
M&A
Pages
« first
‹ previous
1
2
3
4
5
6
next ›
last »